-

SAI MedPartners Enhances Its Competitive Intelligence Capabilities Through the Acquisition of The Dunn Group

READING, Pa.--(BUSINESS WIRE)--SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased to announce that it has acquired The Dunn Group (“TDG”). Northlane Capital Partners (“NCP”) partnered with management to acquire SAI in June 2022.

TDG, headquartered in Totowa, NJ, is a competitive intelligence firm that focuses on providing primary business intelligence to clients in the pharmaceutical and biotechnology industries. TDG delivers competitive landscape insights by analyzing pipelines, tracking therapy areas, and conducting analogue assessments. The acquisition of TDG will enhance SAI’s core competitive intelligence offering.

“We are excited to welcome the Dunn Group to the SAI platform. The Dunn Group has a longstanding legacy in providing competitive intelligence services to the healthcare industry, and we look forward to working with Stu and his team to further deepen our relationships with our clients and continue to provide best-in-class services," stated Erik Nordhoy, Founder and CEO of SAI.

ABOUT SAI MEDPARTNERS

SAI is a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries. Headquartered in Reading, Pennsylvania, SAI provides best-in-class competitive intelligence and strategy support services to assist its clients across the product development lifecycle. SAI works with leading multinational pharmaceutical companies, in addition to a growing number of biotechnology and medical device companies. SAI has a presence across the United States, Europe, and Asia. For more information, please visit www.sai-med.com.

ABOUT NORTHLANE CAPITAL PARTNERS

Based in Bethesda, MD, NCP is a middle market private equity firm focused on key segments within the healthcare and business services sectors, where its principals have invested $1.8 billion of equity capital. NCP’s strategy is to partner with industry leading companies and great management teams, aligning incentives to accelerate growth and build value. For more information, please visit www.northlanecapital.com.

Contacts

SAI CONTACT

Erik Nordhoy, CEO
(610) 685-4204

NCP CONTACTS

Eugene Krichevsky, Partner
(301) 841-1399

JJ Carbonell, Partner
(301) 841-1420

Anna Ellingboe, Vice President
(301) 272-9992

NORTHLANE CAPITAL PARTNERS


Release Versions

Contacts

SAI CONTACT

Erik Nordhoy, CEO
(610) 685-4204

NCP CONTACTS

Eugene Krichevsky, Partner
(301) 841-1399

JJ Carbonell, Partner
(301) 841-1420

Anna Ellingboe, Vice President
(301) 272-9992

More News From NORTHLANE CAPITAL PARTNERS

Northlane Capital Partners Announces Final Close of Oversubscribed Fund III at $750 Million

BETHESDA, Md.--(BUSINESS WIRE)--Northlane Capital Partners (“Northlane” or “NCP”) announced today the final closing of its oversubscribed third private equity fund, Northlane Capital Partners III LP (“NCP III” or “Fund III”), at its hard cap of $750 million. The total raised substantially surpassed Fund III’s $550 million target and reflects notable growth from its $408 million predecessor. Global investors include pension funds, insurance companies, endowments and foundations, asset managers,...

Northlane Capital Partners Announces the Sale of Empower Community Care

BETHESDA, Md.--(BUSINESS WIRE)--Northlane Capital Partners (“NCP”) announced today the sale of Empower Community Care (“Empower” or the “Company”) to NexPhase Capital, LP (“NexPhase”). Founded in 2016, Empower is an established global behavioral health organization offering proprietary treatments and services to help at-risk youth, their families, and caregivers. The Company does not directly administer the treatment but instead provides its state and municipal clients with training and support...

Northlane Capital Partners Announces the Sale of The Difference Card

BETHESDA, Md.--(BUSINESS WIRE)--Northlane Capital Partners (“NCP”) announced today the sale of The Difference Card (“TDC” or the Company) to funds managed by Stone Point Capital LLC. Founded in 2001, TDC is a provider of healthcare cost containment solutions that enable employers to reduce healthcare insurance costs without reducing employees’ benefit levels or increasing employees’ out-of-pocket expenses. By utilizing card technology, risk transfer solutions, and proprietary wellness strategie...
Back to Newsroom